結直腸癌肝轉移的治療進展_《中國普外基礎與臨床雜志》

作者：

許劍民 , 徐博

復旦大學附屬中山醫院普外科，復旦大學普通外科研究所（上海 200032）;

關鍵詞：

結直腸癌肝轉移

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 許劍民,徐博. 結直腸癌肝轉移的治療進展. 中國普外基礎與臨床雜志, 2011, 18(11): 1135-1137. doi: 復制

1.	Arru M, Aldrighetti L, Castoldi R, et al. Analysis of prognostic factors influencing longterm survival after hepatic resection for metastatic colorectal cancer [J]. World J Surg, 2008, 32(1): 93103.
2.	Van den Eynde M, Hendlisz A. Treatment of colorectal liver metastases: a review [J]. Rev Recent Clin Trials, 2009, 4(1): 5662.
3.	中華醫學會外科學分會胃腸外科學組，中華醫學會外科學分會結直腸肛門外科學組，中國抗癌協會大腸癌專業委員會．結直腸癌肝轉移診斷和綜合治療指南(V 2010) [J]．中華胃腸外科雜志， 2010， 13（6）： 457470．.
4.	Aranda E, Abad A, Carrato A, et al. Treatment recommendations for metastatic colorectal cancer [J]. Clin Transl Oncol, 2011, 13(3): 162178.
5.	Kanso F, Adam R. Surgery of hepatic metastasis in colorectal cancers [J]. Rev Prat, 2010, 60(8): 11081110.
6.	Spigel DR, Greco FA, Waterhouse D, et al. Phase Ⅱ trial of FOLFOX6, bevacizumab, and cetuximab in the firstline treatment of metastatic colorectal cancer [J]. Clin Adv Hematol Oncol, 2010, 8(7): 480485，489.
7.	Turrini O, Viret F, Guiramand J, et al. Strategies for the treatment of synchronous liver metastasis [J]. Eur J Surg Oncol, 2007, 33(6): 735740.
8.	Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J]. Lancet Oncol, 2010, 11(1): 3847.
9.	Mariani P. The safety of perioperative bevacizumab use [J]. J Chir (Paris), 2010, 147 (Suppl 1): S12S17.
10.	Welch S, Spithoff K, Rumble RB, et al. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review [J]. Ann Oncol, 2010, 21(6): 11521162.
11.	Raoul JL, Van Laethem JL, Peeters M, et al. Cetuximab in combination with irinotecan/5fluorouracil/folinic acid(FOLFIRI)in the initial treatment of metastatic colorectal cancer: a multicentre twopart phase Ⅰ/Ⅱ study [J]. BMC Cancer, 2009, 9: 112.
12.	Stang A, Fischbach R, Teichmann W, et al. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases [J]. Eur J Cancer, 2009, 45(10): 17481756.
13.	Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage Ⅳ colorectal cancer receiving combination chemotherapy without surgery as initial treatment [J]. J Clin Oncol, 2009, 27(20): 33793384.
14.	Aslam MI, Kelkar A, Sharpe D, et al. Ten years experience of managing the primary tumours in patients with stage Ⅳ colorectal cancers [J]. Int J Surg, 2010, 8(4): 305313.
15.	Stillwell AP, Buettner PG, Ho YH. Metaanalysis of survival of patients with stage Ⅳ colorectal Cancer managed with surgical resection versus chemotherapy alone [J]. World J Surg, 2010, 34(4): 797807.
16.	Karoui M, RoudotThoraval F, Mesli F, et al. Primary colectomy in patients with stage Ⅳ colon Cancer and unresectable distant metastases improves overall survival: results of a multicentric study [J]. Dis Colon Rectum, 2011, 54(8): 930938.
17.	Lin BS, Ziogas A, Seery TE, et al. Role of surgical resection among chemotherapytreated patients with colorectal cancer stage Ⅳ disease: A survival analysis [J]. J Clin Oncol, 2011, 29(15): 3564.
18.	Mocellin S, Pasquali S, Nitti D. FluoropyrimidineHAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer [J]. Cochrane Database Syst Rev， 2009，（3）: CD007823.
19.	Zabaleta J, Aguinagalde B, Fuentes MG, et al. Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor[J]. Eur J Surg Oncol, 2011, 37(9): 786790.
20.	Lin BR, Chang TC, Lee YC, et al. Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor [J]. Ann Surg Oncol, 2009, 16(4): 10261032.
21.	Adam R, de Haas RJ, Wicherts DA, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? [J]. Ann Surg, 2011, 253(2): 349359.
22.	Stillwell AP, Ho YH, Veitch C. Systematic review of prognostic factors related to overall survival in patients with stage Ⅳ colorectal cancer and unresectable metastases [J]. World J Surg, 2011, 35(3): 684692.

1. Arru M, Aldrighetti L, Castoldi R, et al. Analysis of prognostic factors influencing longterm survival after hepatic resection for metastatic colorectal cancer [J]. World J Surg, 2008, 32(1): 93103.
2. Van den Eynde M, Hendlisz A. Treatment of colorectal liver metastases: a review [J]. Rev Recent Clin Trials, 2009, 4(1): 5662.
3. 中華醫學會外科學分會胃腸外科學組，中華醫學會外科學分會結直腸肛門外科學組，中國抗癌協會大腸癌專業委員會．結直腸癌肝轉移診斷和綜合治療指南(V 2010) [J]．中華胃腸外科雜志， 2010， 13（6）： 457470．.
4. Aranda E, Abad A, Carrato A, et al. Treatment recommendations for metastatic colorectal cancer [J]. Clin Transl Oncol, 2011, 13(3): 162178.
5. Kanso F, Adam R. Surgery of hepatic metastasis in colorectal cancers [J]. Rev Prat, 2010, 60(8): 11081110.
6. Spigel DR, Greco FA, Waterhouse D, et al. Phase Ⅱ trial of FOLFOX6, bevacizumab, and cetuximab in the firstline treatment of metastatic colorectal cancer [J]. Clin Adv Hematol Oncol, 2010, 8(7): 480485，489.
7. Turrini O, Viret F, Guiramand J, et al. Strategies for the treatment of synchronous liver metastasis [J]. Eur J Surg Oncol, 2007, 33(6): 735740.
8. Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J]. Lancet Oncol, 2010, 11(1): 3847.
9. Mariani P. The safety of perioperative bevacizumab use [J]. J Chir (Paris), 2010, 147 (Suppl 1): S12S17.
10. Welch S, Spithoff K, Rumble RB, et al. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review [J]. Ann Oncol, 2010, 21(6): 11521162.
11. Raoul JL, Van Laethem JL, Peeters M, et al. Cetuximab in combination with irinotecan/5fluorouracil/folinic acid(FOLFIRI)in the initial treatment of metastatic colorectal cancer: a multicentre twopart phase Ⅰ/Ⅱ study [J]. BMC Cancer, 2009, 9: 112.
12. Stang A, Fischbach R, Teichmann W, et al. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases [J]. Eur J Cancer, 2009, 45(10): 17481756.
13. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage Ⅳ colorectal cancer receiving combination chemotherapy without surgery as initial treatment [J]. J Clin Oncol, 2009, 27(20): 33793384.
14. Aslam MI, Kelkar A, Sharpe D, et al. Ten years experience of managing the primary tumours in patients with stage Ⅳ colorectal cancers [J]. Int J Surg, 2010, 8(4): 305313.
15. Stillwell AP, Buettner PG, Ho YH. Metaanalysis of survival of patients with stage Ⅳ colorectal Cancer managed with surgical resection versus chemotherapy alone [J]. World J Surg, 2010, 34(4): 797807.
16. Karoui M, RoudotThoraval F, Mesli F, et al. Primary colectomy in patients with stage Ⅳ colon Cancer and unresectable distant metastases improves overall survival: results of a multicentric study [J]. Dis Colon Rectum, 2011, 54(8): 930938.
17. Lin BS, Ziogas A, Seery TE, et al. Role of surgical resection among chemotherapytreated patients with colorectal cancer stage Ⅳ disease: A survival analysis [J]. J Clin Oncol, 2011, 29(15): 3564.
18. Mocellin S, Pasquali S, Nitti D. FluoropyrimidineHAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer [J]. Cochrane Database Syst Rev， 2009，（3）: CD007823.
19. Zabaleta J, Aguinagalde B, Fuentes MG, et al. Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor[J]. Eur J Surg Oncol, 2011, 37(9): 786790.
20. Lin BR, Chang TC, Lee YC, et al. Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor [J]. Ann Surg Oncol, 2009, 16(4): 10261032.
21. Adam R, de Haas RJ, Wicherts DA, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? [J]. Ann Surg, 2011, 253(2): 349359.
22. Stillwell AP, Ho YH, Veitch C. Systematic review of prognostic factors related to overall survival in patients with stage Ⅳ colorectal cancer and unresectable metastases [J]. World J Surg, 2011, 35(3): 684692.

《中國普外基礎與臨床雜志》

結直腸癌肝轉移的治療進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

結直腸癌肝轉移的治療進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料